Low-Dose Aspirin Does Not Prevent Depression in Older Adults
No significant difference seen in incidence rate of new CES-D-10 scores of ≥8 for aspirin, placebo
Depression
Pharmacogenetics in Antidepressant Selection for Major Depressive Disorder
Presently, clinicians should be urged to view genetics as an additional tool in choosing prescriptions for MDD, as opposed to a replacement for complete clinical evaluation.
Unapproved Cannabidiol, Curcumin Injectables Marketed for Multiple Disorders Recalled
Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.
Boxed Warning Added to Montelukast Labeling Regarding Neuropsychiatric Events
Because the benefits of montelukast may not outweigh the potential risk of neuropsychiatric symptoms in patients with allergic rhinitis, use should be reserved for patients who have an inadequate response or intolerance to alternative therapies.
FDA: Guidance on Digital Therapeutics for Psychiatric Disorders During COVID-19
The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.
Physician Depressive Symptoms Tied to Higher Risk for Medical Errors
Bidirectional association seen between depressive symptoms and medical errors
Teens Using Oral Contraceptives Report More Depressive Symptoms
No association seen between oral contraceptives, depressive symptoms when ages 16 to 25 years were combined
Sertraline Does Not Reduce Depressive Symptoms by Week 6
Improvements seen in anxiety symptoms, mental health-related QoL, not depressive symptoms
Esketamine Promising in Patients With MDD Who Have Active Suicidal Ideation With Intent
Results from both studies showed that treatment with esketamine plus standard of care was clinically meaningful and statistically significantly superior to placebo plus standard of care.
Adolescent Oral Contraceptive Use Tied to Later Depression Risk
Findings show long-term impact, regardless of current oral contraception use in adulthood
